Live Breaking News & Updates on Nasdaq Trml|Page 2
Stay updated with breaking news from Nasdaq trml. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leerink Partnrs reiterated their outperform rating on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research report released on Thursday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Tourmaline Bio’s FY2026 earnings at ($4.00) EPS. A number of other research firms also recently weighed in on TRML. HC Wainwright reaffirmed a buy rating […] ....
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued to investors on Thursday, December 7th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($4.00) per share for the year. Leerink Partnrs […] ....
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) Director Parvinder Thiara bought 1,000 shares of Tourmaline Bio stock in a transaction dated Friday, November 17th. The stock was purchased at an average price of $17.31 per share, with a total value of $17,310.00. Following the purchase, the director now directly owns 83,782 shares in the […] ....
Truist Financial initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The firm issued a buy rating and a $43.00 target price on the stock. TRML has been the topic of several other reports. Piper Sandler assumed coverage on shares of […] ....
Analysts at Truist Financial began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report released on Friday, Marketbeat.com reports. The brokerage set a “buy” rating and a $43.00 price target on the stock. Truist Financial’s target price indicates a potential upside of 160.92% from the company’s previous close. TRML has […] ....